K.-P. Hartmann, M. Heuschmann / Tetrahedron 56 (2000) 4213±4218
4217
water (20 mL). Drying in vacuo yielded 13.5 g (73%) of
analytically clean 5b as orange crystals with mp 204±
(C-2/6, Ar); 140.2 (C-4, Ar); 163.1 (C-3); 168.2 (C-6).
UV/VIS (CHCl3): lmax548 (log e3.919), 2.76 (3.539).
Anal. Calcd for C17H16N4 (276.3): C, 73.89; H, 5.79; N,
20.08. Found: C, 73.56; H, 5.77; N, 20.27.
1
2058C. H NMR (CD3OD, 400 MHz): 2.48 (s, Me); 7.25
(5-H, Ar); 7.27 (3-H, Ar); 7.35 (4-H, Ar); 7.45 (3/5-H,
4-H, Ph); 7.68 (2/6-H, Ph); 7.69 (6-H, Ar). 13C NMR
(CD3OD, 100 MHz): 19.8 (Me); 126.1 (C-3/5, Ph); 126.2
(C-5, Ar); 128.9 (C-2/6, Ph); 128.9 (C-6, Ar); 130.1 (C-4,
Ar); 130.2 (C-1, Ar); 130.7 (C-1, Ph); 130.7 (C-3, Ar); 131.0
(C-4, Ph); 137.0 (C-2, Ar); 148.6 (C-6); 149.9 (C-3). UV
(CH3CN): lmax335 (log e3.972). Anal. Calcd for
C15H14N4 (250.3): C, 71.98; H, 5.63; N, 22.38. Found: C,
72.05; H, 5.64; N, 22.18.
2,3-Dihydro-3,6-diphenyl-3-[1-(4,5-dihydro-1,3-dimethyl-
2-imidazolio)cyclopropyl]-1,2,4,5-tetrazinide (7a).1 To a
suspension of red tetrazine 4a (550 mg, 2.35 mmol) in
20 mL toluene at 2308C 2 (400 mg, 2.89 mmol) was
added dropwise. After 3 h at 2158C the color of the pre-
cipitate had changed to orange. The yellow solid was
collected in a cooled glass ®lter, washed with toluene and
dried for two days in vacuo at 2208C to yield 780 mg (86%)
7a.
1,2-Dihydro-3-phenyl-6-(2,4,6-trimethylphenyl)tetrazine
(5c). To a solution of oxadiazole 3c (6.41 g, 24.3 mmol) in
125 ml acetonitrile absolute hydrazine hydrate (1.22 g,
24.4 mmol) was added dropwise and the mixture was stirred
for 1 h at 40±508C. The yellow precipitate was collected by
®ltration, washed with acetonitrile (3£20 mL) and degassed
water (20 mL). Drying in vacuo yielded 4.33 g (64%) of
analytically clean 5c as orange crystals with mp 2208C.
1H NMR (CD3OD, 400 MHz): 2.30 (s, 4-Me); 2.32 (s,
2/6-Me); 6.90 (3/5-H, Ar); 7.44 (3/5-H, 4-H, Ph); 7.67
(2/6-H, Ph). 13C NMR (CD3OD, 100 MHz): 19.4 (2/6-
Me); 21.2 (4-Me); 126.1 (C-3/5, Ph); 128.5 (C-3/5, Ar);
128.9 (C-2/6, Ph); 129.1 (C-1, Ar); 130.4 (C-1, Ph); 130.6
(C-4, Ph); 137.4 (C-2/6, Ar);139.5 (C-4, Ar); 148.4 (C-3);
149.4 (C-6). UV (CH3CN): lmax340 (log e3.715). Anal.
Calcd for C17H18N4 (278.4): C, 73.35; H, 6.52; N, 20.13.
Found: C, 73.10; H, 6.02; N, 20.06.
2,3-Dihydro-3-(2-methylphenyl)-6-phenyl-3-[1-(4,5-di-
hydro-1,3-dimethyl-2-imidazolio)cyclopropyl]-1,2,4,5-
tetrazinide (7b) and 2,3-dihydro-6-(2-methylphenyl)-3-
phenyl-3-[1-(4,5-dihydro-1,3-dimethyl-2-imidazolio)cyclo-
propyl]-1,2,4,5-tetrazinide (8b). To a solution of tetrazine
4b (693 mg, 2.79 mmol) in 30 mL THF at 2108C a
precooled solution of 6 (404 mg, 2.93 mmol) in 5 mL
THF was added slowly. After the color had changed to
orange, the yellow solid (1.02 g, 95%) was collected in a
cooled glass ®lter, washed with pentane and dried in vacuo
at 2208C. A solution of this solid in CD2Cl2 was prepared at
2508C and characterized by NMR spectroscopy as a
mixture of 7b and 8b (33:67). 1H NMR (CD2Cl2,
400 MHz, 2508C): 7b: 0.92 (mc, 2H, cPr); 1.32 (mc, 2H,
cPr); 2.44 (Me, Ar); 3.16 (s, N±Me); 3.26 (s, N±Me); 3.58
(mc, N±CH2); 3.74 (mc, N±CH2); 6.85 (5-H, Ar); 6.90 (3-H,
Ar); 6.99 (4-H, Ar); 6.99 (4-H, Ph); 7.14 (3/5-H, Ph); 7.43
(6-H, Ar); 7.53 (2/6-H, Ph). 8b: 0.92 (mc, 2H, cPr); 1.54 (mc,
2H, cPr); 1.75 (Me, Ar); 3.14 (s, 2N±Me); 3.61 (mc, 2N±
CH2); 6.94 (3-H, Ar); 6.94 (5-H, Ar); 7.04 (4-H, Ar); 7.09
(3/5-H, Ph); 7.13 (4-H, Ph); 7.35 (2/6-H, Ph); 7.88 (6-H,
Ar). 13C NMR (CD2Cl2, 100 MHz, 2508C): 7b: 10.1
(2CH2, cPr); 22.5 (cPr); 24.5 (Me, Ar); 35.4 (N±Me); 35.8
(N±Me); 49.60 (N±CH2); 49.7 (N±CH2); 87.0 (C-3, tetra-
zinide); 122.0 (C-2/6, Ph); 124.2 (C-3, Ar); 125.1 (C-4, Ph);
127.5 (C-4, Ar); 128.2 (C-3/5, Ph); 130.1 (C-6, Ar); 131.3
(C-3-Ar); 136.8 (C-1, Ar); 136.9 (C-1, Ph); 139.9 (C-2, Ar);
157.6 (C-6, tetrazinide); 168.4 (C-2, imidazolium). 8b: 10.4
(2CH2, cPr); 21.1 (Me, Ar); 23.4 (cPr); 35.3 (2N±Me);
49.61 (2N±CH2); 84.5 (C-3, tetrazinide); 124.8 (C-6, Ar);
125.40 (C-5, Ar); 127.1 (C-3/5, Ph); 125.43 (C-4, Ar); 128.1
(C-4, Ph); 129.0 (C-2/6, Ph); 130.9 (C-3, Ar); 134.3 (C-2,
Ar); 136.0 (C-1, Ar); 139.6 (C-1, Ph); 157.7 (C-6, tetra-
zinide); 168.8 (C-2, imidazolium).
3-(2-Methylphenyl)-6-phenyltetrazine (4b). A 6 N solu-
tion of NaNO2 in water (25 mL, 150 mmol) was added drop-
wise to 18 mL of conc. HCl (ca. 180 mmol). The resulting
nitrous gases were bubbled through a suspension of 5b
(3.90 g, 15.4 mmol) in 15 mL of CH2Cl2 cooled to 08C.
After 0.5 h the solvent was evaporated and the residue
recrystallized from methanol/ethanol to give 3.30 g (85%)
1
of 4b as violet±red needles with mp 93±948C. H NMR
(CDCl3, 400 MHz): 2.70 (s, Me); 7.38±7.46 (m, 4/5-H,
Ar), 7.50 (4-H, Ph); 7.58±7.67 (m, 3/5-H, Ph; 3-H, Ar);
8.17 (6-H, Ar); 8.67 (2/6-H, Ph). 13C NMR (CDCl3, 20.2
MHz): 21.6 (Me); 126.5 (C-5, Ar); 128.1 (C-3/5, Ph); 129.2
(C-2/6, Ph); 130.9 (C-3, Ar); 131.3 (C-1, Ph); 131.4 (C-6,
Ar); 131.6 (C-1, Ar); 132.0 (C-4, Ar); 132.6 (C-4, Ph); 138.7
(C-4, Ar); 162.7 (C-6); 166.9 (C-3). UV/VIS (CHCl3):
lmax545 (log e3.073), 288 (3.683). Anal. Calcd for
C15H12N4 (248.3): C, 72.56; H, 4.87; N, 22.57. Found: C,
72.82; H, 4.93; N, 22.29.
3-Phenyl-6-(2,4,6-trimethylphenyl)tetrazine (4c). A 6 N
solution of NaNO2 in water (25 mL, 150 mmol) was
added dropwise to 18 mL of conc. HCl (ca. 180 mmol).
The resulting nitrous gases were bubbled through a suspen-
sion of 5c (4.33 g, 15.6 mmol) in 15 mL of CH2Cl2 cooled to
08C. After 20 min the solvent was evaporated and the resi-
due recrystallized from methanol/ethanol to give 3.35 g
2,3-Dihydro-3-phenyl-6-(2,4,6-trimethylphenyl)-3-[1-(4,5-
dihydro-1,3-dimethyl-2-imidazolio)cyclopropyl]-1,2,4,5-
tetrazinide (8c). To a solution of tetrazine 4c (304 mg,
1.10 mmol) in 10 mL THF at 2108C a precooled solution
of 6 (176 mg, 1.27 mmol) was added slowly. After the color
had changed to orange, the solvent was evaporated and the
remaining yellow solid (437 mg, 96%) dried in vacuo at
2208C. A solution of this solid in CD2Cl2 was prepared at
1
(78%) of 4c as violet±red needles with mp 98±998C. H
1
NMR (CDCl3, 400 MHz): 2.17 (2/6-Me); 2.38 (4-Me);
7.00 (3/5-H, Ar); 7.58 (3/5-H, 4-H, Ph); 8.63 (2/6-H, Ph).
13C NMR (CDCl3, 100 MHz): 20.2 (2/6-Me); 21.3 (4-Me);
128.2 (C-3/5, Ph); 129.0 (C-3/5, Ar); 129.3 (C-2/6, Ph);
130.0 (C-1, Ph); 131.8 (C-1 Ar); 132.8 (C-4, Ph); 137.2
2508C and characterized by NMR spectroscopy as 8c. H
NMR (CD2Cl2, 400 MHz, 2508C): 0.95 (mc, 2H, cPr); 1.74
(mc, 2H, cPr); 1.51 (2/6-Me, Ar); 2.20 (4-Me, Ar); 3.06 (s,
2N±Me); 3.70 (mc, N±CH2); 3.83 (mc, N±CH2); 6.71 (3/5-
H, Ar); 7.10±7.22 (3/4/5-H, Ph); 7.44 (2/6-H, Ph). 13C NMR